What Does uniQure Do?

Total employees343
HeadquartersAmsterdam
Founded1998

uniQure N.V. is a pioneering gene therapy company dedicated to developing and delivering transformative treatments for patients with severe genetic diseases. With a strong focus on AAV (Adeno-Associated Virus)-based therapies, uniQure leverages its innovative technology platform, state-of-the-art manufacturing capabilities in Lexington, MA, and Amsterdam, and deep scientific expertise to advance a pipeline of product candidates. Their lead product, HEMGENIX® (etranacogene dezaparvovec), is the first and only approved gene therapy for hemophilia B. uniQure is also advancing programs in Huntington's disease (AMT-130), amyotrophic lateral sclerosis (ALS), Fabry disease, and other rare conditions.

Where Is uniQure's Headquarters?

uniQure officeuniQure officeuniQure officeuniQure office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the company's registered office and principal executive hub, overseeing global strategy, corporate governance, finance, and European commercial operations.

Notable Features:

Located in an area conducive to biotech innovation, likely offering modern office spaces designed to foster collaboration and support corporate functions. The proximity to other life science companies and academic institutions in the Amsterdam Science Park area is a key advantage.

Work Culture:

Characterized by a science-driven, innovative, and patient-focused environment. Employees are typically highly skilled and dedicated to advancing gene therapy, working collaboratively towards shared goals in a dynamic and international setting.

HQ Significance:

The Amsterdam headquarters underscores uniQure's European roots and provides strategic access to European markets, regulatory agencies (like the EMA), and a diverse talent pool. It's central to their global corporate identity and operations.

Values Reflected in HQ: The headquarters' location and function reflect uniQure's commitment to scientific excellence, global collaboration, innovation, and its mission to deliver life-altering therapies to patients worldwide.

Location:

uniQure maintains a significant global presence with key operational hubs in Amsterdam (Netherlands) for corporate and European activities, and Lexington (Massachusetts, USA) for extensive R&D, manufacturing, and U.S. operations. A commercial office in Zurich (Switzerland) further supports its European market engagement. This strategically distributed footprint enables uniQure to conduct global clinical trials, manage complex international manufacturing and supply chains, engage with regulatory authorities like the FDA and EMA, and execute the commercialization of its gene therapies in key markets worldwide.

Street Address:

Paasheuvelweg 25

City:

Amsterdam

State/Province:

North Holland

Country:

Netherlands

Where Else Does uniQure Operate Around the World?

Lexington, Massachusetts, USA

Address: 121 Hartwell Avenue, Lexington, MA 02421, USA

Critical for uniQure's North American strategy, including R&D, manufacturing of clinical and commercial product, clinical trial execution, regulatory interactions with the FDA, and commercial activities in the U.S. market.

Zurich, Switzerland

Address: uniQure GmbH, Zollikerstrasse 181, 8008 Zürich, Switzerland

Facilitates engagement with the Swiss healthcare ecosystem, regulatory bodies, and key opinion leaders, supporting the commercialization and patient access for uniQure's therapies in the region.

Buying Intent Signals for uniQure

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading uniQure? Meet the Executive Team

As of April 2025, uniQure' leadership includes:

Matt Kapusta - Chief Executive Officer
Walid Abi-Saab, M.D. - Chief Medical Officer
Pierre Caloz - Chief Financial Officer
Ricardo Dolmetsch, Ph.D. - President and Chief Scientific Officer
Eileen Freitag, J.D. - Chief People and ESG Officer
Richard Deeley, Ph.D. - Chief Technology Officer
Paul Spence - Chief Operating Officer

Who's Investing in uniQure?

uniQure has been backed by several prominent investors over the years, including:

Nantahala Capital Management, LLC
EcoR1 Capital, LLC
Redmile Group, LLC
BlackRock Fund Advisors
The Vanguard Group, Inc.

What Leadership Changes Has uniQure Seen Recently?

Hire3
Exits2

Over the past 12 months, uniQure has made significant updates to its executive team, including appointing a new Chief Operating Officer, a new Chief Financial Officer, and a new Chief People and ESG Officer. These changes were accompanied by the planned departure of the former CFO and the Chief Commercial Officer.

Departures

Christian Klemt, Christian Klemt departed as Chief Financial Officer after a transition period with his successor.
Daniel Leonard, Daniel Leonard, former Chief Commercial Officer, departed from uniQure.

New Appointments:

Paul Spence, Paul Spence was appointed as Chief Operating Officer to oversee manufacturing, supply chain, and operations.
Pierre Caloz, Pierre Caloz joined uniQure as Chief Financial Officer, bringing strong financial leadership experience.
Eileen Freitag, Eileen Freitag was appointed to the newly created role of Chief People and ESG Officer.

What Technology (Tech Stack) Is Used byuniQure?

Discover the tools uniQure uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

uniQure Email Formats and Examples

uniQure commonly utilizes standard professional email formats for its employees. The most frequently observed pattern is the first initial followed by a period and the full last name, or the full first name followed by a period and the full last name, at the uniqure.com domain.

f.lastname@uniqure.com or first.lastname@uniqure.com

Format

j.doe@uniqure.com or jane.doe@uniqure.com

Example

80%

Success rate

What's the Latest News About uniQure?

GlobeNewswire • May 7, 2024

uniQure Reports First Quarter 2024 Financial Results and Highlights Company Progress

uniQure N.V. announced its financial results for the first quarter ended March 31, 2024, and provided updates on its pipeline, including HEMGENIX® revenues and progress in its Huntington's disease and other gene therapy programs....more

GlobeNewswire • April 4, 2024

uniQure Appoints Seasoned Biopharma Executive Paul Spence as Chief Operating Officer

uniQure N.V. announced the appointment of Paul Spence as its new Chief Operating Officer, effective April 15, 2024. Mr. Spence brings over two decades of experience in biopharmaceutical operations, manufacturing, and supply chain management to uniQure....more

GlobeNewswire • February 27, 2024

uniQure Announces Pierre Caloz to Succeed Christian Klemt as Chief Financial Officer

uniQure N.V. announced that Pierre Caloz would be appointed Chief Financial Officer, effective March 11, 2024, succeeding Christian Klemt, who departed the Company following a transition period....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including uniQure, are just a search away.